作者: Naoki Yamashita , Aritsune Ohho , Akihiro Yamasaki , Miho Kurokawa , Kazuhiro Kotoh
DOI: 10.1007/S00535-013-0921-Z
关键词:
摘要: Background Due to advances in interferon (IFN) therapy for chronic hepatitis C, most elderly patients, and even many of those with advanced hepatic fibrosis, now achieve a sustained virological response (SVR). However, carcinogenesis remains problematic these patients. Hence, we aimed elucidate risk factors hepatocarcinogenesis SVR patients present an appropriate follow-up protocol improving outcomes.